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state valuation data. Recently, researchers started to explore the use
of nonparametric Bayesian methods in this area. Objectives: We
present a nonparametric Bayesian model to estimate a preference-
based index for two condition-speciﬁc ﬁve-dimensional health state
classiﬁcations, one for asthma (ﬁve-dimensional Asthma Quality of
Life Utility Index) and the other for overactive bladder (ﬁve-dimen-
sional Overactive Bladder Quality of Life-Utility Index). Methods:
Samples of 307 and 311 members of the UK general population valued
99 health states selected from a total of 3125 health states deﬁned by
each of the measures using the time trade-off technique. The article
presents the results of the nonparametric model and compares it with
the original model estimated using a conventional parametric
random-effects model. The different methods are compared theoret-
ically and in terms of empirical performance across the two data sets.
It also reports the effect of respondent characteristics on health state
valuations. Results: The nonparametric models were found to beee front matter Copyright & 2014, International S
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than without in terms of root mean square error and the patterns of
standardized residuals. Some respondent characteristics were found
to explain variation in health state values, but these did not have
a signiﬁcant effect on the health states values when estimates
were adjusted for sample differences with the general population.
Conclusions: The nonparametric Bayesian models are theoretically
more appropriate than previously used parametric models and pro-
vide better utility estimates from the two condition-speciﬁc measures.
Furthermore, the model is more ﬂexible in estimating the effect of
covariates.
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Preference-based measures of health-related quality of life are
widely used to calculate quality-adjusted life-years (QALYs) for
use in cost-effectiveness analyses. There are currently a number
of generic preference-based measures, including the EuroQol ﬁve-
dimensional (EQ-5D) questionnaire [1], health utilities index 2
(HUI2) and 3 [2,3], 15D [4,5], Assessment of Quality of Life [6],
Quality of Well-Being [7], and the six-dimensional health state
short form (derived from short-form 36 health survey) (SF-6D) [8].
Condition-speciﬁc preference-based measures have also been
developed, such as for rhinitis [9], cancer [10], erectile dysfunction
[11], overactive bladder [12], dementia [13], and urinary incon-
tinence [14]. These measures have standardized multidimen-
sional health state classiﬁcations with preference or utility
weights elicited from a sample of the general population [15,16].
Their health state classiﬁcations, however, generate a large
number of unique health states, so it is not feasible to obtain
direct valuations for each health state. Models have to beestimated to predict the values for all states deﬁned by the
classiﬁcation on the basis of direct valuations of a sample of
states.
The distribution of health state values generated from time
trade-off (TTO) and standard gamble (SG) tasks is typically skewed,
truncated, noncontinuous, and hierarchical, and so present a major
challenge for conventional statistical modeling [8]. Previous stat-
istical models of these data have met with some success in the SF-
6D [8], the EQ-5D questionnaire [17], and the HUI2 [18], but there are
concerns with the size of the prediction errors and an apparent
systematic pattern in the prediction errors (involving overprediction
of the value of the poor health states and underprediction of the
value of good health states). Furthermore, these methods are
limited in the way they are able to model the effect of covariates
on health state values. Covariates are modeled only in terms of
their effect on the intercept, and these results in the intercept
deviating from unity, which violates the requirement that full
health equals one on the conventional full health-death scale used
to estimate QALYs. It also makes the unrealistic assumption thatociety for Pharmacoeconomics and Outcomes Research (ISPOR).
nce from the University of York and is at Kuwait University,
3060, Kuwait.
thematics, University of York, York YO24 3NB, UK.
Table 1 – Asthma quality-of-life classiﬁcation
(AQL-5D).
Concern
1. Feel concerned about having asthma none of the time
2. Feel concerned about having asthma a little or hardly any of
the time
3. Feel concerned about having asthma some of the time
4. Feel concerned about having asthma most of the time
5. Feel concerned about having asthma all of the time
Short of breath
1. Feel short of breath as a result of asthma none of the time
2. Feel short of breath as a result of asthma a little or hardly any
of the time
3. Feel short of breath as a result of asthma some of the time
4. Feel short of breath as a result of asthma most of the time
5. Feel short of breath as a result of asthma all of the time
Weather and pollution
1. Experience asthma symptoms as a result of air pollution none
of the time
2. Experience asthma symptoms as a result of air pollution a little
or hardly any of the time
3. Experience asthma symptoms as a result of air pollution some
of the time
4. Experience asthma symptoms as a result of air pollution most
V A L U E I N H E A L T H 1 7 ( 2 0 1 4 ) 4 0 6 – 4 1 5 407covariates have the same effect regardless of the state (e.g., the
effect is the same regardless of the severity of the state).
An alternative nonparametric Bayesian method for modeling
health state preference data for handling these problems has
been developed [19]. This method describes the intrinsic charac-
teristics of individual health state valuation data in a way that is
more theoretically appropriate than with previously used para-
metric models. It is also more ﬂexible to take into account the
effect of covariates. This method of modeling has been applied to
SF-6D SG health state valuation data [20] and extended to address
covariates [21]. It has also been applied to a generic measure for
children, the HUI2 UK with SG valuation data [22]. In this article,
we report on the application of this method to TTO data for two
condition-speciﬁc preference-based measures: the ﬁve-
dimensional Asthma Quality of Life Utility Index (AQL-5D) for
asthma and the ﬁve-dimensional Overactive Bladder Quality of
Life-Utility Index (OAB-5D) for overactive bladder. The results are
compared with the conventional random-effect regression mod-
els for each data set. This article extends the method to two
condition-speciﬁc measures and provides important evidence on
the advantages of this approach to modeling TTO data.
The second section of this article brieﬂy describes the AQL-5D
and OAB-5D valuation studies and the data used in this article.
The next section brieﬂy sets out the parametric and nonpara-
metric approaches for health state valuations. The fourth section
presents the results from each approach and compares the
models in terms of their ability to predict actual values and to
estimate the effect of covariates. The last section concludes with
a discussion of the results and their implication for future use of
these measures and modeling work in this ﬁeld.of the time
5. Experience asthma symptoms as a result of air pollution all of
the time
Sleep
1. Asthma interferes with getting a good night’s sleep none of
the time
2. Asthma interferes with getting a good night’s sleep a little or
hardly any of the time
3. Asthma interferes with getting a good night’s sleep some of
the time
4. Asthma interferes with getting a good night’s sleep most of
the time
5. Asthma interferes with getting a good night’s sleep all of the time
Activities
1. Overall, not at all limited with all the activities done
2. Overall, a little limitation with all the activities done
3. Overall, moderate or some limitation with all the activities done
4. Overall, extremely or very limited with all the activities done
5. Overall, totally limited with all the activities done
AQL-5D, ﬁve-dimensional Asthma Quality of Life Utility Index.The Valuation Survey and Data Set
The Health State Classiﬁcations
AQL-5D
The AQL-5D is a health state classiﬁcation system [23] developed
from the Asthma Quality of Life Questionnaire [24]. The dimen-
sions of the AQL-5D are concern about asthma, shortness of
breath, weather and pollution stimuli, sleep impact, and activity
limitations (Table 1). The health state classiﬁcation system has
ﬁve dimensions, each with ﬁve levels of severity, with level 1
denoting no problems and level 5 indicating extreme problems.
By selecting one level for each dimension, it is possible to deﬁne
3125 health states.
OAB-5D
The OAB-5D is a health state classiﬁcation system [25] developed
from the Overactive Bladder Questionnaire [12]. The dimensions
of the OAB-5D are urge, urine loss, sleep, coping, and concern
(Table 2). The health state classiﬁcation system has the same
structure as the AQL-5D, deﬁning a total of 3125 health states.
The Surveys
The respondents were randomly sampled from the general
population using the electoral register of names and address
from within South Yorkshire, United Kingdom [11,12]. The TTO
technique was chosen for eliciting preference values, which asks
respondents to trade off between length of life and quality of life.
The survey used the interviewer-administered TTO-prop method
developed by the York Measurement and Valuation Health
Group, which uses a “time board” as a visual aid [26]. This version
of TTO was selected because it has been shown to be more
reliable than a nonprops version [27]. Furthermore, it has been
used to value the EQ-5D questionnaire.The selection of health states was determined by the speci-
ﬁcation of the model to be estimated. In all 99 health states were
selected out of the 3125 possible health states deﬁned by the
classiﬁcation. The selection was on the basis of a balanced
design, which ensured that any dimension-level (level λ of
dimension δ) had an equal chance of being combined with all
levels of the other dimensions. These 99 states were stratiﬁed
into severity groups on the basis of their total level score across
the dimensions (simply the sum of the levels), and then ran-
domly allocated into 14 blocks, so that each block has 7 health
Table 2 – Overactive bladder quality-of-life classiﬁ-
cation system (OAB-5D).
Urge
1. Not at all bothered by an uncomfortable urge to urinate
2. Bothered by an uncomfortable urge to urinate a little bit or
somewhat
3. Bothered by an uncomfortable urge to urinate quite a bit
4. Bothered by an uncomfortable urge to urinate a great deal
5. Bothered by an uncomfortable urge to urinate a very great deal
Urine loss
1. Not at all bothered by urine loss associated with a strong desire to
urinate
2. Bothered by urine loss associated with a strong desire to urinate
a little bit or somewhat
3. Bothered by urine loss associated with a strong desire to urinate
quite a bit
4. Bothered by urine loss associated with a strong desire to urinate
a great deal
5. Bothered by urine loss associated with a strong desire to urinate
a very great deal
Sleep
1. Bladder symptoms interfered with your ability to get a good
night’s rest none of the time
2. Bladder symptoms interfered with your ability to get a good
night’s rest a little of the time
3. Bladder symptoms interfered with your ability to get a good
night’s rest some of the time
4. Bladder symptoms interfered with your ability to get a good
night’s rest a good bit or most of the time
5. Bladder symptoms interfered with your ability to get a good
night’s rest all of the time
Coping
1. Bladder symptoms caused you to plan “escape routes” to
restrooms in public places none of the time
2. Bladder symptoms caused you to plan “escape routes” to
restrooms in public places a little of the time
3. Bladder symptoms caused you to plan “escape routes” to
restrooms in public places some of the time
4. Bladder symptoms caused you to plan “escape routes” to
restrooms in public places a good bit or most of the time
5. Bladder symptoms interfered with your ability to get a good
night’s rest all of the time
Concern
1. Bladder symptoms caused you embarrassment none of the time
2. Bladder symptoms caused you embarrassment a little of the time
3. Bladder symptoms caused you embarrassment some of the time
4. Bladder symptoms caused you embarrassment a good bit or most
of the time
5. Bladder symptoms caused you embarrassment all of the time
OAB-5D, ﬁve-dimensional Overactive Bladder Quality of Life-
Utility Index.
Table 3 – Characteristics of respondents in valua-
tion surveys.
Characteristic n (%)
AQL-5D OAB-5D
Total 307 311
Age (y)
18–25 34 (11.1) 37 (11.9)
26–35 57 (18.6) 57 (18.3)
36–45 61 (19.9) 61 (19.6)
46–55 50 (16.3) 51 (16.4)
56–65 45 (14.7) 45 (14.5)
466 60 (19.5) 60 (19.3)
Female 168 (54.7) 160 (51.4)
Married or living with partner 214 (69.8) 217 (69.8)
Experienced serious illness
In family 194 (63.4) 176 (56.6)
In themselves 94 (30.6) 94 (30.2)
Degree or equivalent 69 (22.5) 85 (27.3)
Education after 17 y 140 (45.6) 182 (58.5)
Renting property 64 (20.8) 63 (20.2)
Found valuation tasks in interview
difﬁcult
Very difﬁcult 24 (7.9) 13 (4.2)
Quite difﬁcult 82 (26.7) 80 (25.9)
Neither difﬁcult nor easy 52 (16.9) 70 (22.7)
Self-reported EQ-5D questionnaire
scores
Male, female 0.83, 0.84 0.88, 0.88
AQL-5D, ﬁve-dimensional Asthma Quality of Life Utility Index; EQ-
5D, EuroQol ﬁve-dimensional; OAB-5D, ﬁve-dimensional Overac-
tive Bladder Quality of Life-Utility Index.
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allocated 1 of the 14 blocks, received a set of states balanced in
terms of severity and that each state was valued the samenumber of times apart from the pits state, which was valued by
all respondents (see [11,12] for more details).
Respondents
Three hundred seven members of the public (response rate of 40%)
in South Yorkshire (UK) were interviewed in the AQL-5D survey,
and 311 people were interviewed in the OAB-5D survey (response
rate of 26.7%). Table 3 shows that the two samples were very similar
in terms of their sociodemographic composition. Among the
respondents to the AQL-5D survey, 53 (17.3%) had asthma and in
the OAB-5D survey, 27 (8.7%) reported experiencing symptoms of
urge and 18 (5.8%) reported urine loss for at least some of the time.
Overall self-reported health status using the EQ-5D questionnaire
was very close to the UK EQ-5D questionnaire norms of 0.85 for
females and 0.86 for males [28].
The Data Set
AQL-5D
There were 2455 TTO health state valuations generated by the 307
respondents from the interviews. The average number of TTO
valuations per intermediate health state was 22 (range, 19–22) and
the worst possible state (AQL-5D state 55555) was valued by every
respondent (n ¼ 307). Mean TTO health state values ranged from
0.39 to 0.94 and generally had fairly large SDs (around 0.2–0.4). The
distribution of the values was negatively skewed.
OAB-5D
There were 2487 health state values generated by the 311
respondents. Each intermediate health state was valued 22
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5D 55555) was valued 310 times using TTO (one missing value).
Mean TTO health state values ranged from 0.56 for the worst
possible state, to 0.91 for state 13321, with an average SD of 0.28.Modeling
The aim of modeling is to estimate health state utility values for
all states deﬁned by each classiﬁcation. The utility associated with
a health state is assumed to be a function of that state; hence, by
estimating a relationship between the descriptive system and the
observed values we can infer values for all states. In previous
models of utility data, we have used parametric relationships with
assumptions about functional form, but here we contrast this
conventional parametric approach reported by Yang et al. [11,12]
with a more ﬂexible Bayesian nonparametric model.
A general model for health state valuations can be described
by Kharroubi et al. [19]:
yij¼ f Xij,αj
 þεij, ð1Þ
where for i ¼ 1, 2,…, nj and j ¼ 1, 2,…, m, xij is the ith health state
valued by respondent j and the dependent variable yij is the TTO
score given by respondent j for that health state. The general
model has two sets of independent, zero-mean, random effect
terms: εij is a random error term associated with each observation
and αj is a term to allow for individual characteristics of
respondent j.
The interpretation of f Xij,αj
 
is as the true indifference TTO
value that respondent j has for health state Xij. The objective is to
obtain a health state utility measure for the population as a
whole, and this is generally taken to be the mean of the
respondent-level health state utilities across the population. To
account for different populations, it is possible to model αj in
terms of respondent-level covariates such as age, sex, or socio-
economic factors.The Parametric Approach
Yang et al. [11,12] specify the following model for respondent j’s
health state utility:
f Xij,αj
 ¼μþh0I Xij
 þαj, ð2Þ
where μ and h denote unknown parameters and I Xij
 
is a vector
of dummy explanatory variables. In the simplest, no-interactions,
case of this model, I Xij
 
is a vector of terms Iδλ Xij
 
for each level λ
> 1 of dimension δ of the AQL-5D and/or OAB-5D. For example,
I32 Xij
 
denotes dimension δ ¼ 3 (weather and pollution in the
AQL-5D; sleep in the OAB-5D), level λ ¼ 2 (experience asthma
symptoms as a result of air pollution a little or hardly any of the
time in the AQL-5D; bladder symptoms interfered with your
ability to get a good night’s rest a little of the time in the OAB-
5D). For any given health state Xij, Iδλ Xij
 
is deﬁned as follows:
Iδλ Xij
  ¼ 1 if, for state Xij, dimension δ is at level λ.
Iδλ Xij
  ¼ 0 if, for state Xij, dimension δ is not at level λ.
In all, there are 25 of these terms, with level λ ¼ 1 acting as a
baseline for each dimension. Hence, the intercept parameter μ
represents the health state utility value for state (11111), and
summing the coefﬁcients θδλ of the “on” dummies and adding this
to the intercept derives the value of any other state.
More generally, I Xij
 
can include additional dummy variables
to account for interactions between the levels of different
dimensions, and the model selected by Yang et al. [11,12]
included one such term, Interaction dummy in the AQL-5D and
N2_severe in the OAB-5D, each of which takes the value of1 when two or more dimensions in a health state were greater
than level 4 and 0 otherwise.
Estimation of this random-effects model is via generalized
least squares or maximum likelihood. Because αj has zero mean,
the population health state utility for state x in this model is
simply μ^þ h^0I Xð Þ.
The Nonparametric Approach
The Bayesian statistical nonparametric model describes the
characteristics of individual health state valuation data in such
a way that for respondent j, the health state utility of state Xij is
f Xij,αj
 ¼1exp αj
 
1u Xij
  
: ð3Þ
Note that the individual respondent term αj enters multiplica-
tively rather than additively as in Equation 2. The term u(x) is the
median health state utility of health state x. (In the Kharroubi et al. [19]
model, the distribution of αj is normal, so it has zero median as well
as zero mean, and the median of exp αj
 
is therefore 1.) It is treated
as an unknown function and in the Bayesian framework it therefore
becomes a random variable. The prior distribution for u(x) is
u Xð ÞN γþb0X,s2 , ð4Þ
Note that x is a vector comprising discrete levels on each of the
ﬁve health dimensions. Note also that themean function of Equation
4 represents a belief that the utility will be approximately linear and
additive in different dimensions. This is not at all the same thing as
model (2). Although model (2) imposes this linearity and additivity as
a strict assumption about the utility function, model (4) simply
expresses it as a prior expectation. (It is to be noted that linearity in
each dimension is inappropriate because it is not reasonable to
suppose that utility should drop by the same amount when wemove
from level 2 to 3 on a dimension as when we move from level 1 to 2.
In the EQ-5D questionnaire, for instance, the levels in each dimen-
sion are of the form “no restriction” [in health or ability to function],
“some restriction,” “severe restriction,” and there is no reason to
suppose that the step from “none” to “some” has the same health
impact as from “some” to “severe.” Additivity may also be inappro-
priate, with some interaction to be expected. Linearity and additivity,
however, can be overcome by models using a transformation
function, a power or logarithmic function say. More on this is given
in Kharroubi et al. [19].) The actual function is free to vary around this
mean according to its multivariate normal distribution, and so it may
take absolutely any form. It is in this sense that we describe our
model as nonparametric, and we believe that this is another way in
which our model is more realistic than that of Yang et al. [11,12]. See
Kharroubi et al. [19] for more explanation of this part of the model.
Furthermore, the values of u Xð Þ and u X0ð Þ for two different
states x and X0 have a correlation c X,X0ð Þ that decreases as the
distance between x and X0 increases. This is deﬁned as
c X,X0ð Þ¼exp ∑bd xdx0d
 2n o,
where for d ¼ 1, 2, …, 5, xd and x0d are the levels of dimension d in
health states x and X0, respectively, and bd is a roughness parameter
that controls how closely the true utility function is expected to
adhere to a linear form in dimension d [19]. The effect of this
function is to assert that if x and X0 describe very similar health
states (in the sense that their levels are the same or close in all
dimensions) their utilities will be approximately the same, and so the
preference function varies smoothly as the health state changes.
Note that the mean health state utility in Equation 3 is
u Xð Þ¼1α 1u Xð Þ ,
where α is the mean value of exp αð Þ over the whole population.
This will not in general be 1, and so the population (mean) health
state utility is not the same as the median health state utility
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of α are given in Kharroubi et al. [19].
Note also that the variable αj is allowed to vary because this
captures the effect of respondent characteristics. Suppose that tj
is the vector of covariates for respondent j, we then propose
αjN t0jθ,τ2
 
where θ is the vector of coefﬁcients for the covariates. Note here
that t’s are centered to ensure that they have zero means, and
hence the value of exp αð Þ for a typical person is 1.
The models and the programs to apply the Bayesian approach
have been written in Matlab and are available on request.Comparison of Models
The two models cannot be compared in terms of a simple table of
coefﬁcients as is the case in parametric models because the
nonparametric model produces in effect a separate parameter for
every one of the 3125 health states. Given the overall aim is to
predict health state valuation, the best way to compare these
models is via their predictive ability. This includes plots of
predicted to actual values, calculations of the root mean squared
error (RMSE), and plots of standardized residuals. These assess-
ments are undertaken within the full estimation sample and inFig. 1 – Sample mean and predicted health states valuations for
the parametric model. (A) AQL-5D. (B) OAB-5D. AQL-5D, ﬁve-
dimensional Asthma Quality of Life Utility Index; OAB-5D, ﬁve-
dimensional Overactive Bladder Quality of Life-Utility Index.
Fig. 2 – Sample mean and predicted health states valuations
for the nonparametric model. (A) AQL-5D. (B) OAB-5D. AQL-
5D, ﬁve-dimensional Asthma Quality of Life Utility Index;
OAB-5D, ﬁve-dimensional Overactive Bladder Quality of Life-
Utility Index.an out of sample random selection of 10 states by re-estimating
the models using data sets excluding these 10 states.Results
The predictive ability of the two methods of modeling data is
compared in Figures 1 and 2 for the two data sets. Figure 1 presents
the predicted mean health state valuations (line marked with
squares) for the parametric model (2), along with actual mean
health state valuations (line marked with diamonds), with health
states ordered by predicted health state values (Figs 1 and 2 have
been plotted by ordering states in terms of their predicted values
rather than observed values as presented in Yang et al. [11,12]. This
is better on statistical grounds and easier to interpret.). The line
marked with triangles represents the errors obtained by the differ-
ence between the two valuations. Figure 2 presents the same plots
for the nonparametric model. These plots suggest that parametric
models have a tendency to overpredict the value of the better
states, whereas this does not seem to have been a problem for the
nonparametric model. However, there is some suggestion that
predictions are below those observed across the board in the OAB
Table 4 – Inference for a selection of health states.
A. AQL-5D
Health
states
N Observed
mean
Mean  SD
Nonparameteric posterior
inference (no covariates)
Parameteric
posterior inference
Nonparameteric posterior
inference (covariates)
11233 21 0.8390 0.8115  0.0283 0.9280  0.0762 0.8125  0.0283
12543 24 0.7475 0.7081  0.0364 0.7801  0.0724 0.7084  0.0356
14225 25 0.7580 0.6720  0.0366 0.6970  0.0706 0.6719  0.0358
15311 21 0.7643 0.7616  0.0363 0.8306  0.0744 0.7619  0.0361
21223 25 0.8156 0.8082  0.0270 0.9094  0.0705 0.8088  0.0265
23312 21 0.9376 0.8176  0.0332 0.8476  0.0765 0.8172  0.0326
24422 19 0.7232 0.7527  0.0272 0.7883  0.0797 0.7532  0.0263
25421 24 0.7921 0.7623  0.0307 0.8100  0.0719 0.7627  0.0292
31215 22 0.7141 0.6933  0.0351 0.7372  0.0740 0.6959  0.0339
32435 19 0.6916 0.7046  0.0340 0.7075  0.0799 0.7055  0.0339
33511 21 0.9014 0.7761  0.0400 0.7936  0.0757 0.7760  0.0394
34554 19 0.4905 0.5359  0.0392 0.5116  0.0803 0.5369  0.0383
41125 25 0.6876 0.7033  0.0325 0.7624  0.0693 0.7033  0.0324
42214 23 0.7400 0.6976  0.0313 0.7530  0.0730 0.6992  0.0299
43234 23 0.7074 0.7000  0.0309 0.7237  0.0738 0.7010  0.0292
45341 23 0.7704 0.7020  0.0373 0.7444  0.0742 0.7023  0.0356
51454 23 0.5896 0.5533  0.0415 0.6359  0.0730 0.5550  0.0395
52444 23 0.7009 0.6175  0.0380 0.6449  0.0730 0.6173  0.0364
53532 25 0.7388 0.6363  0.0367 0.7396  0.0705 0.6353  0.0359
55424 21 0.7819 0.5600  0.0513 0.5940  0.0767 0.5587  0.0490
55555 307 0.3912 0.3811  0.0377 0.4258  0.0253 0.3828  0.0345
B. OAB-5D
Health
states
N Observed
mean
Mean  SD
Nonparameteric posterior
inference (no covariates)
Parameteric
posterior inference
Nonparameteric posterior
inference (covariates)
11233 21 0.8624 0.8350  0.0243 0.9060  0.0715 0.8356  0.0247
12543 20 0.8305 0.7375  0.0301 0.8645  0.0736 0.7355  0.0310
13514 20 0.8005 0.7365  0.0311 0.8160  0.0727 0.7355  0.0325
15251 22 0.8368 0.7348  0.0315 0.8703  0.0699 0.7352  0.0323
21113 25 0.8404 0.8018  0.0262 0.9187  0.0646 0.7999  0.0274
23235 24 0.6617 0.6545  0.0267 0.7269  0.0676 0.6524  0.0294
23312 19 0.9058 0.7930  0.0268 0.8623  0.0754 0.7922  0.0277
24422 24 0.7017 0.7510  0.0225 0.8460  0.0674 0.7506  0.0231
25421 20 0.8320 0.7925  0.0245 0.8683  0.0733 0.7917  0.0254
31215 27 0.7519 0.7027  0.0267 0.8056  0.0632 0.7007  0.0287
32435 24 0.5496 0.6381  0.0296 0.7480  0.0676 0.6375  0.0318
33511 18 0.9144 0.7767  0.0314 0.8667  0.0766 0.7753  0.0323
34554 24 0.5900 0.6548  0.0293 0.7347  0.0678 0.6553  0.0308
35422 20 0.8270 0.7219  0.0276 0.8442  0.0739 0.7208  0.0285
35453 23 0.7196 0.6889  0.0283 0.7662  0.0688 0.6883  0.0305
41211 22 0.8809 0.7896  0.0274 0.9017  0.0695 0.7898  0.0282
42325 24 0.7279 0.6565  0.0284 0.7544  0.0679 0.6544  0.0301
44135 20 0.7705 0.6759  0.0309 0.7453  0.0732 0.6717  0.0319
45143 21 0.7957 0.7054  0.0312 0.8221  0.0718 0.7043  0.0331
45253 21 0.7671 0.6704  0.0314 0.7525  0.0721 0.6707  0.0329
51451 22 0.8514 0.7413  0.0334 0.7985  0.0697 0.7428  0.0339
52314 18 0.8333 0.8260  0.0307 0.7938  0.0774 0.8260  0.0330
53525 25 0.6752 0.6167  0.0355 0.6726  0.0657 0.6124  0.0392
54333 24 0.7071 0.6828  0.0261 0.8011  0.0686 0.6807  0.0292
55555 310 0.5656 0.5464  0.0300 0.6173  0.0230 0.5448  0.0331
AQL-5D, ﬁve-dimensional Asthma Quality of Life Utility Index; OAB-5D, ﬁve-dimensional Overactive Bladder Quality of Life-Utility Index.
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for the better or worst states, whereas the parametric model seems
to predict higher utilities than those observed in the OAB (Fig. 1B).
Table 4 shows the inference for the mean health state utility
values of a sample of 20 health states. These health states were
selected at random from the 99 states valued in the sample to
ensure a balance of mild, moderate, and severe states. For each
state, Table 4 reports the observed sample mean health state utility
and the predicted mean and SD for the population mean health
state utility from both nonparametric and parametric models. It
shows that across the two surveys the predictive performance of
the nonparametric model is better than that of the parametric
model overall, with an RMSE of 0.06 for the nonparametric model
and 0.07 for the parametric model for both data sets.
No state is estimated as being worse than death in either data
set. Important differences, however, can be seen between the
models from Table 4. For AQL-5D, the parametric model esti-
mates the health state utility for the pits state to be 0.4258, even
though the observed average for this state is 0.3912, whereas the
nonparametric model achieves a value of 0.3811. For OAB-5D, theFig. 3 – Standardized residuals for the parametric model for
each of the 2455 individual health state valuations. (A) AQL-
5D. (B) OAB-5D. AQL-5D, ﬁve-dimensional Asthma Quality of
Life Utility Index; OAB-5D, ﬁve-dimensional Overactive
Bladder Quality of Life-Utility Index.parametric estimate was 0.6173 compared with an observed
mean of 0.5656, but the nonparametric model gave 0.5464. The
SDs of the predictions are larger for parametric models because
they are based on the assumption that the preference function is
additive in the various factors, apart from the interaction dummy
term. The posterior SDs are smaller, and this is mainly because it
is a model that allows uncertainty in the shape of the health state
utility function.
The validity of the assumed models is examined in Figure 3,
which shows a histogram of standardized residuals across all
2455 health state valuations for the parametric model, and
Figure 4 shows the corresponding standardized residuals for the
nonparametric model. According to these models, we would
expect these to be approximately N (0, 1). Figures 3 and 4 broadly
support this, although there is some evidence of skewness, which
is more obvious in Figure 3. This is not surprising, given the
negative skewness in the original TTO data at the individual
level. The degree of skewness, however, is probably not high
enough to invalidate the analyses in both models, which assume
normally distributed errors.Fig. 4 – Standardized residuals for the nonparametric model
for each of the 2455 individual health state valuation. (A)
AQL-5D. (B) QAB-5D. AQL-5D, ﬁve-dimensional Asthma
Quality of Life Utility Index; OAB-5D, ﬁve-dimensional
Overactive Bladder Quality of Life-Utility Index.
Table 5 – Out of sample predictions for 10 health states.
A. AQL-5D
Missing state N True sample mean Mean  SD
Nonparameteric posterior inference Parameteric posterior inference
11445 22 0.6982 0.6665  0.0788 0.6921  0.0784
14225 25 0.7580 0.7789  0.0628 0.6721  0.0745
21113 25 0.8864 0.7941  0.0693 0.9142  0.0706
24422 19 0.7232 0.7494  0.0582 0.7730  0.0833
31143 23 0.8074 0.8177  0.0543 0.8745  0.0764
33245 22 0.7191 0.6850  0.0564 0.6526  0.0779
41112 23 0.8926 0.8784  0.0531 0.9069  0.0732
42542 19 0.7111 0.6756  0.0628 0.7359  0.0829
52141 20 0.8420 0.8149  0.0815 0.8730  0.0813
54333 23 0.7178 0.7120  0.0589 0.7060  0.0790
B. OAB-5D
Missing state N True sample mean Mean  SD
Nonparameteric posterior inference Parameteric posterior inference
13321 20 0.9120 0.8388  0.0441 0.9108  0.0740
15331 23 0.8709 0.8141  0.0423 0.9089  0.0695
23534 25 0.7088 0.7679  0.0388 0.7652  0.0681
25425 22 0.7564 0.7560  0.0435 0.7394  0.0715
32441 21 0.8324 0.8301  0.0411 0.8993  0.0728
35422 20 0.8270 0.8365  0.0402 0.8624  0.0760
42245 24 0.6587 0.6717  0.0402 0.7282  0.0685
45532 20 0.7110 0.7304  0.0508 0.8002  0.0760
53242 20 0.7930 0.7510  0.0447 0.7804  0.0754
55521 23 0.7770 0.7530  0.0528 0.8237  0.0697
AQL-5D, ﬁve-dimensional Asthma Quality of Life Utility Index; OAB-5D, ﬁve-dimensional Overactive Bladder Quality of Life-Utility Index.
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ability to predict the values for states that have not been used in
the estimation. To do this, 10 health states were removed
randomly from the estimation data, and the models ﬁtted on
data for the remaining 89 states. The observed sample means for
the 10 omitted states, together with their predicted mean and SD
values from the parametric and nonparametric models esti-
mated, are compared for the reduced data set in Table 5. It can
be seen that the nonparametric model predicts the omitted data
quite well and better than does the parametric model. Overall,
the predictive performance of the nonparametric model is better
than that of the parametric model, with RMSEs of 0.037 compared
with 0.046, respectively, for the AQL-5D and 0.038 compared with
0.051 for the OAB-5D. The predicted SDs for both models are
larger than those in Table 4, because the model in Table 4 is
predicting the data on which it was estimated, whereas the
model in Table 5 is predicting out of sample data. The parametric
standard errors are larger than the nonparametric ones, primarily
because the nonparametric analysis is able to make use of other
evaluations by the same respondents to estimate their individual
random effects, which the frequentist analysis cannot do.
The Q-Q plots of standardized predictive errors for the 10
health states sample means are presented in Figures 5 and 6. The
dotted line on each is the ﬁtted and corresponds to a reference
line passing through ﬁrst and third quartiles, which indicates
whether the points are linear. The solid line corresponds to the
theoretical N(0,1) distribution. Figure 5 suggests that the para-
metric models are not well validated, particularly for the AOB-5D.
In contrast, Figure 6 shows that nonparametric model predictionsare well validated. Very similar results were obtained in ﬁve
replications.
The analysis of covariates suggested that sex and age had
some effect on AQL-5D health state values and experience of
illness and age had some effect on OAB-5D values. Education did
not have any discernible impact. As reported earlier, the age and
sex distributions of respondents included in the two studies were
different from those excluded and from the UK population as a
whole. Therefore, we have examined the overall effect of adjust-
ing for covariates on the values of the health states listed in
Table 3. Actual UK age and sex distributions were taken from the
UK census of 2011 [28]. The resultant posterior mean health state
values were found to be almost identical to those that estimated
the age and sex distributions from the valuation surveys, with
differences of less than 0.005 in mean health state values.Discussion
In this article, we have applied nonparametric methods to the
existing AQL-5D and OAB-5D valuation data in an attempt to
overcome some of the limitations observed when a parametric
approach has been used. It extends methods used to model the
SF-6D and HUI2 valuation data nonparametrically [19,22] to two
condition-speciﬁc measures and applies them to TTO health
state utility data. The Bayesian main-effects models estimated
on two data sets have been compared with the conventional
main effects model [11,12]. The ﬂexibility of the nonparametric
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Fig. 5 – Q-Q plot of standardized predictive errors for the
parametric model for the 10 out of sample health states. (A)
AQL-5D. (B) OAB-5D. AQL-5D, ﬁve-dimensional Asthma
Quality of Life Utility Index; OAB-5D, ﬁve-dimensional
Overactive Bladder Quality of Life-Utility Index.
Fig. 6 – Q-Q plot of standardized predictive errors for the
nonparametric model for the 10 out of sample health states.
(A) AQL-5D. (B) OAB-5D. AQL-5D, ﬁve-dimensional Asthma
Quality of Life Utility Index; OAB-5D, ﬁve-dimensional
Overactive Bladder Quality of Life-Utility Index.
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state values has also been used.
The nonparametric model is able to represent more accurately
than the conventional parametric random-effects model the
nature of individual respondent effects, the repeated measure-
ments from each individual, and the skew distribution of indi-
vidual valuations of a given state. The model also allows for
respondent-level covariates to enter in a natural way as predic-
tors of individual respondent effects.
As reported earlier, the covariates analysis showed that age
and sex have strong effects on AQL-5D values and age and illness
have a strong effect on OAQ-5D values. However, the overall
effect of these background variables on the original posterior
mean health state values after adjusting for age and sex were
quite modest (typically 0.0045 or less). The descriptive content of
the instruments seem to have been more important than these
characteristics of the respondents examined in this article in
explaining the variation in TTO values. Kharroubi at al. [21] drew
a similar conclusion from their analysis of the SF-6D data.
The nonparametric model achieved improvements to the
predictive ability in terms of a better RMSE and standardized
predictive errors in the out of sample validation. Although the
improvement in mean squared error is quite modest in thisexample, there are other important advantages over and above
the mean difference. Our model produces1. predictions that are much better behaved and do not violate
logical consistency,2. a utility function that better captures the lower utilities in the
data for the poorest health states, and3. posterior variances that correctly validate against the
leftout data.
The extra ﬂexibility of the nonparametric model and
improved performance come at the expense of computational
complexity and specialist software is needed to estimate the
preference function (see [19] for details). The beneﬁts are worth
this extra given the expense of collecting good quality utility data
from respondents. The programs developed for these applica-
tions can be readily adapted to other data sets with appropriate
expertise.
The complexity of the modeling has little implication for
those simply wishing to generate health state utility values from
Asthma Quality of Life Questionnaire or Overactive Bladder
Questionnaire data sets (e.g., from data collected in a clinical
trial). The results can be readily applied using straightforward
V A L U E I N H E A L T H 1 7 ( 2 0 1 4 ) 4 0 6 – 4 1 5 415Excel programs that have a procedure for undertaking a simple
look-up procedure.
An alternative semi-parametric approach to health state
valuation for handling these problems has been developed by
Mendez et al. [29]. Their approach makes no assumption on the
distribution of health state valuations, allows for an undeter-
mined amount of heterogeneity in the estimates, and accommo-
dates covariates in a ﬂexible way. It is important to compare our
approach to that applied by Mendez et al. in the future to make
best use of health state valuation data.
This article presents nonparametric models to estimate a
Bayesian preference-based index for two ﬁve-dimensional health
state classiﬁcations, one for asthma (AQL-5D) and the other for
overactive bladder (OAB-5D). It also reports on the effect of
respondent characteristics on health state valuations. The non-
parametric Bayesian models are theoretically more appropriate
than previously used parametric models and provide better utility
estimates from the two condition-speciﬁc measures. Furthermore,
the model is more ﬂexible in estimating the effect of covariates.Acknowledgments
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